Polyol pathway in the pathogenesis of diabetic complications and aldose reductase inhibitors
- PMID: 1307356
Polyol pathway in the pathogenesis of diabetic complications and aldose reductase inhibitors
Similar articles
-
[The role of polyol pathways in formation of diabetic cataracts].Klin Oczna. 1997;99(6):401-4. Klin Oczna. 1997. PMID: 9685789 Review. Polish.
-
[Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].Nihon Rinsho. 1987 Dec;45(12):3010-27. Nihon Rinsho. 1987. PMID: 3128677 Review. Japanese. No abstract available.
-
Aldose reductase and its inhibition in the control of diabetic complications.Ann Clin Lab Sci. 1993 Mar-Apr;23(2):148-58. Ann Clin Lab Sci. 1993. PMID: 8457142 Review.
-
Potential use of aldose reductase inhibitors to prevent diabetic complications.Clin Pharm. 1990 Jun;9(6):446-57. Clin Pharm. 1990. PMID: 2114249 Review.
-
Aldose reductase in diabetic cataracts.JAMA. 1981 Jul 17;246(3):257-61. JAMA. 1981. PMID: 6787220 No abstract available.
Cited by
-
Inhibitory effects and actions of pentacyclic triterpenes upon glycation.Biomedicine (Taipei). 2015 Sep;5(3):13. doi: 10.7603/s40681-015-0013-x. Epub 2015 Aug 11. Biomedicine (Taipei). 2015. PMID: 26260291 Free PMC article.